In vitro and in vivo testing methods of epigenomic endpoints for evaluating endocrine disruptors
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Epigenetic modulations underlie critical developmental processes and contribute to determining adult phenotype. Alterations to the phenotype, due to exposure to environmental insults during sensitive periods of development, are mediated through alterations in epigenetic programming in affected tissues. Originally prepared for the Organisation of Economic Cooperation and Development (OECD), this detailed review evaluates the potential role of chemical-induced epigenetic modifications to endocrine signaling pathways during sensitive windows of exposure as a mechanism of endocrine disruption, along with the examination of potential methods for assessing such disruption. Potential targets of disruption along putative adverse outcome pathways associated with the signaling pathways are identified, along with assays that show promise in evaluating the target in a screening and testing program such that in vitro methods are used where possible, and animal experiments only where in vitro methods are not available. Monitoring such epigenetic marks in response to toxicant exposure may in future provide a valuable tool for predicting adverse outcomes, but a more robust basis for Test Guideline recommendations is still needed. Although there is evidence to suggest that epigenomic dysregulation might mediate effects of exposures to endocrine disruptors, it is uncertain as to whether these changes are truly predictive of adverse outcome(s). Adverse effects observed in the OECD transgenerational assays could be used to inform future tests specifically designed to investigate the epigenetic mechanism of action. Follow-up studies should include both an epigenetic as well as a genomic component to differentiate between the contributions of potentially compensatory mechanisms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012 · cited 3×
“Altex 30, 4/13 449 thing, Table 1 vastly oversimplifies the problem – histone H3 lysine 9 trimethylation (H3K9me3) is only one of hundreds of post-translational modifications of the canonical core histones (H2A, H2B, H3, and H4) (Bannister and Kouzarides, 2011), be-”
BackgroundInfluentialEpigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 2×
“There is now a substantial amount of information to suggest that cis-regulatory sequences in the genome are frequently located far from promoters (Heintzman et al., 2007), and that these loci may be preferentially involved in mediating disease states, as found by Thompson et al.”
BackgroundEpigenetic Reprogramming in Mammalian Development
Reik, W., Dean, W., & Walter, J. (2001) · Science · doi:10.1126/science.1063443 · Cited by 3,078 · cited 4×
“The vinclozolin-induced changes in methylation would have to survive two massive waves of demethylation of DNA genome-wide, one occurring early during spermatogenesis (at the fetal stage, following the differentiation of primordial germ cells into early spermatogenic cells), and a second demethylation wave early in em…”
BackgroundInfluentialGenome-scale DNA methylation maps of pluripotent and differentiated cells
Meissner, A., Mikkelsen, T. S., Gu, H., Wernig, M., Hanna, J., Sivachenko, A., Zhang, X., Bernstein, B. E., Nusbaum, C., Jaffe, D. B., et al. (2008) · Nature · doi:10.1038/nature07107 · Cited by 2,536
Genomic DNA methylation: the mark and its mediators.
Klose, R. J., & Bird, A. P. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.008 · Cited by 2,501 · cited 1×
“…at gene promoters Hartley and Madhani, 2009 Chromatin looping Kit regulation by Gata1/Gata2 Jing et al., 2008 DNA modifications Cytosine methylation Klose and Bird, 2006 DNA structural variation R-loop formation Roy et al., 2008 RNA-mediated Antisense RNA transcription Beiter et al., 2009 Altex…”
BackgroundThe Transcriptional Landscape of the Yeast Genome Defined by RNA Sequencing
Nagalakshmi, U., Wang, Z., Waern, K., Shou, C., Raha, D., Gerstein, M., & Snyder, M. (2008) · Science · doi:10.1126/science.1158441 · Cited by 2,479
Transposable elements: targets for early nutritional effects on epigenetic gene regulation
Waterland, R. A., & Jirtle, R. L. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5293-5300.2003 · Cited by 2,019
Exposure of the U.S. Population to Bisphenol A and 4- tertiary -Octylphenol: 2003–2004
Calafat, A. M., Ye, X., Wong, L.-Y., Reidy, J. A., & Needham, L. L. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.10753 · Cited by 1,743 · cited 2×
“Bisphenol A (BPA) has been a major focus of investigation for some time, given its broad exposure within the population (Calafat et al., 2008) and the observed effects in animal models on the development of breast and prostate (reviewed in Weng et al., 2010).”
BackgroundHigh density DNA methylation array with single CpG site resolution
Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J. M., Delano, D., Zhang, L., Schroth, G. P., Gunderson, K. L., et al. (2011) · Genomics · doi:10.1016/j.ygeno.2011.07.007 · Cited by 1,727 · cited 1×
“…groups of CpGs Microarray-based 450K Infinium Methylation Inexpensive, design targeted to regions of BeadChip (Illumina) presumed function (Bibikova et al., 2011) Interrogates limited number of cytosines, informativeness depends on design choices miRNA miRNA-seq Quantitative, can identify…”
Background
Cited by
EDC-2: the endocrine society's second scientific statement on endocrine-disrupting chemicals
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari, J., & Zoeller, R. T. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1010 · Cited by 2,407
Associating cellular epigenetic models with human phenotypes
Lappalainen, T., & Greally, J. M. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.32 · Cited by 282
Self-citationWhy Endocrine Disrupting Chemicals (EDCs) Challenge Traditional Risk Assessment and How to Respond
Futran Fuhrman, V., Tal, A., & Arnon, S. (2015) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.12.012 · Cited by 152
Marí-Bauset, S., Peraita-Costa, I., Donat-Vargas, C., Llopis-González, A., Marí-Sanchis, A., Llopis-Morales, J., & Morales Suárez-Varela, M. (2022) · Autism · doi:10.1177/13623613211039950 · Cited by 10
Metadata
- Authors
- Greally, J.
- Venue
- ALTEX
- Publisher
- ALTEX Edition
- Published
- 2013
- Volume
- 30
- Issue
- 4
- Pages
- 445-471
- ISSN
- 0946-7785 (ISSN-L)
- 1868-596X
- OpenAlex
- W2084377709
- Cited by
- 65
- References
- 20
- FWCI
- 4.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.